Parsippany Chapter Upcoming Events Join PCCI

 

Greene Street Pharmaceuticals

A company that specializes in the formulation and development of abuse deterrent opioid transdermal delivery systems, as well as generic opioid transdermal delivery systems.

 

 

Presenter: Frank Jones, Founder and CEO

 

Monday, June 12, 2017

Embassy Suites, Chesterbrook, Pennsylvania (directions)

 

About

 

greene street is a privately held pharmaceutical company that specializes in the formulation and development of abuse deterrent opioid transdermal delivery systems, as well as generic opioid transdermal delivery systems. They have the know-how and proven experience to direct the formulation and development of transdermal products through a contractual agreement with K&H Pharmaceuticals, LLC.

 

The abuse of opioids, such as FENTANYL has reached epidemic proportions in the United States.  Through discussions with primary care professionals, emergency response personnel, and patients who wear FENTANYL transdermal patches the company has a clear understanding of the path to abuse of opioid transdermal delivery systems.

 

greene street is directing the development of an opioid delivering transdermal patch that is formulated to allow the administration of safe and FDA approved levels of FENTANYL unless the patch is degraded or otherwise diverted for illegal drug abuse. They have advanced development towards the filing of a 505(b)(2) filing for an abuse deterrent FENTANYL transdermal delivery system and an ANDA for a generic FENTANYL transdermal delivery system. 

 

Their path forward is clear: confirm findings through PK and permeation studies, scale up and perfect the technology with the goal to license the products. 

 

Frank Jones, Founder and CEO, has 30+ years in pharma serving in both domestic and international companies in various executive positions and Bill Dixon is a lawyer who for almost 30 years has focused on business support, entrepreneurial development and start-ups.  In 2006 Frank and Bill founded ProSolus Pharmaceuticals, LP (www.prosoluspharma.com) a successful transdermal company that was acquired by Mission Pharmacal in 2015.  Frank and Bill founded greene street Pharmaceuticals, LLC with the desire to leverage their experience in the pharmaceutical transdermal space, to have a meaningful impact on the health of average Americans and to help confront the scourge of opioid addiction.

 

 

3 Major Issues

 

  1. Strategic/business: Currently self funded through development for all products (9 products to date with 4 licenses to date), does it make sense to seek funding to develop on own through FDA submission (ANDA or 505b2) or continue license model.
  2. Strategic: Should the company explore investment for advancing to pilot/pk stage.


  3. Regulatory: Filing strategy - currently ANDA/505b2 - could a medical device route exist for transdermals?

 

Program:

 

6:30 - Cocktails & Dinner (Cash bar and special 2-entree buffet menu)

8:00 - Frank Jones, Founder and CEO, will deliver Greene Street's "Elevator" Pitch to the Group

8:20 - A Panel will address three major issues crucial to helping the Company reach the next level.

9:00 - Open discussion: members and guests

 

 

Available Media

Please note: All information obtained here is the property of those presenting and should not be copied or duplicated without written consent.

 

Slides

None available at this time

Audio

None available at this time

Video

None available at this time

Webcast

Green Street Webcast - 06/12/17


Allow several seconds to load.  It is a high resolution stream.  On your browser, you can set for automatic, or choose lower HD or 480p resolutions (if performance is slow).  

 

00:00:00  Don Skerrett's turnover to Frank Jones
00:00:15  Frank Jones presentation
00:27:35  Panelist introductions
00:29:38  Mark Carvlin, PhD, presentation (panelist 1)
00:42:55  Dawn Eringis presentation (panelist 2)
00:57:08  Bozena Korczak presentation (panelist 3)
01:02:20  Audience questions
01:30:00  End

Contact Info:

 

 

Our Sponsors

EisnerAmperGlaxoSmithKlineKEH Insurance Agency
New Jersey Institute of Technology
Science CenterWhite and Williams

 

<Top of the page>

 

 

 

 

Questions or Coments?

Contact: Peter van der Kam,

peter@rxpcci.com | (610) 296-8086

 

 

 

Good Company! Good Drink! Good Food! Good Program! Good Fun!

 

Site Navigation

HOME  |  ABOUT PCCI  |   MAP / DIRECTIONS  |   JOIN US  |   BOARD MEMBERS  |   AFFILIATES  |  NEXT MEETING  |  ARCHIVES  |  PROFILES

CALENDAR OF EVENTS  |  PARSIPPANY CHAPTER  |  FEEDBACK / COMMENTS  |   CONTACT US

Pharmaceutical Consulting Consortium International, Inc.,

info@rxpcci.com or (610) 296-8086

Meetings Held at Embassy Suites - Valley Forge

888 Chesterbrook Blvd, Chesterbrook, Pennsylvania 19087

All content on this website is copyrighted and should not be reproduced without the consent of PCCI.

© Copyright 2016-2017

 

 

Tat Communication Inc